Abstract
The purpose of this study was to determine if systolic blood pressure (SBP) by itself is sufficient for the JNC-VI (Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure)-based classification of blood pressure of Tehranian adult population. Clinically, SBP and diastolic blood pressure (DBP) are sometimes at different stages in the same individual and the higher stage is considered to classify blood pressure level. The prevalence of disparate levels of SBP and DBP has only recently been noticed. Some researches have reported the importance of SBP level, and not DBP, in determining the appropriate classification of hypertension even in those undergoing treatment. Data were collected for 3823 men and 5159 women aged 20–69 years who were not using antihypertensive medication, in the Tehran Lipid and Glucose Study (TLGS), a cross-sectional phase of a large epidemiological study first established in 1999. The study used the mean of two separate blood pressure measurments in each individual. High blood pressure is defined according to the highest level of SBP or DBP. In 86.3% of the subjects, blood pressure stage was determined according to SBP and in 90.0% of them according to DBP. In 77.4% of the subjects (75.7% of men and 78.7% of women), SBP determined blood pressure in the same stage as DBP did. The role of SBP was the most prominent in age groups 20–29 and 60–69 years (91.4 and 90.8%, respectively) and the least in age group 40–49 years (80.4% of the subjects). DBP had a more prominent role in younger ages and the least significance in older ages. In conclusion, SBP has a more prominent role than DBP in determining blood pressure stage according to JNC-VI only in the 60–69-year-old group. The role of DBP is more prominent in other age groups.
Introduction
According to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI), blood pressure classification is based on the highest stage of systolic blood pressure (SBP) or diastolic blood pressure (DBP).1 Clinically, SBP and DBP are sometimes in different stages in the same individual and the higher stage is considered to classify blood pressure level.2 The prevalence of disparate levels of SBP and DBP has come to attention only recently. Lloyd-Jones et al2 and Pogue et al3 have reported the importance of SBP level, and not DBP, in determining the appropriate classification of hypertension even in those undergoing treatment.4 Moreover, on the basis of the wealth of currently available evidence, the JNC recommends a major paradigm shift in urging that SBP become the major criterion for diagnosis, staging, and therapeutic management of hypertension, particularly in middle-aged and older Americans.5 Framingham Heart Study6 and MRFIT7 even more convincingly demonstrated the pre-eminent value of SBP in the risk prediction of cardiovascular diseases. This phenomenon is also recently emphasised by Dustan.8
In this article, we report our experience employing JNC-VI classification in blood pressure survey in inhabitants of Tehran City who participated in the Tehran Lipid and Glucose Study (TLGS) in 1999–2000.9
Methods
TLGS design and sample
TLGS is a longitudinal study in which the first phase is a cross-sectional study or a baseline examination survey. It has been designed to estimate the prevalence of cardiovascular risk factors including lipid and glucose disorders, obesity, smoking, and hypertension for a representative sample of Iranian urban population in Tehran, No. 13 district. The first phase of this study was performed in the years 1999 and 2000.9
Individuals aged 3–69 years who were under coverage of medical health centres of Lailatolghadr, Mohammadian, and Salavati and were sampled through a random multistage stratified cluster sampling were invited to participate in this study. The crude response rate was approximately 57.5%, and the reasons for nonresponse are now being investigated as to whether there is any essential difference between respondents and nonrespondents.
The data are collected by means of interviews and a questionnaire for demographic data and physical examination for blood pressure, pulse rate and anthropometrical measurements, thyroid examination, and laboratory measurements for lipid profiles, fasting blood sugar (FBS), 2 h post 75 gm glucose test (2 h PG), and serum thyroid hormone measurement. An electrocardiogram is taken for those over 30 years of age. Data are directly stored in Computer-Assisted System software.10 All the procedures mentioned above are conducted at a research unit of the TLGS unit.
Blood pressure measurement
Participants were initially told to rest for 15 min. A qualified physician then measured blood pressure twice during the physical examination in a sitting position after one more measurement for determining peak inflation level using a standard mercury sphygmomanometer calibrated by the Iranian Institute of Standards and Industrial Research. All the physicians were required to participate in a period of specialized training in the use of standardized protocol for measuring the blood pressure. After that, a qualifying exam was held to assure the quality of the procedure. Moreover, satisfactory performance during concordant measurements of blood pressure with an instructor by means of a double-headed Y-shaped stethoscope was a requirement for certification as a TLGS physician as well as retraining and requalifying in definite intervals. A digit preference score was also calculated to ascertain the quality and precision of physicians' performances.11 Based on the circumference of the participant's arm, a regular adult or large cuff was chosen. The cuff was placed on the participant's right arm, and inflated as fast as possible until the cuff pressure was 30 mmHg above the level at which the radial pulse disappeared. There was at least a 30-s interval between these two separate measurements. Thereafter, the mean of the two measurements was considered as the participant's blood pressure, which was entered into the computer. The SBP was defined as the appearance of the first sound (Korotkoff phase 1), and the DBP was defined as the disappearance of the sound (Korotkoff phase 5) during deflation of the cuff at a 2–3 mm/s decrement rate of mercury column. The participants were asked to refrain from drinking tea or coffee, physical activity, and smoking. They were also asked to empty their bladder 30 min preceding the measurement. The study used the mean of two separate BP measurements in each individual, and BP classification was carried out according to the JNC-VI criteria. However, because of low frequency of hypertension stage 3, hypertension stages 2 and 3 were combined together as hypertension stage 2 in the analysis.
The study was approved by the research committee of the Endocrine Research Center and all individuals who participated in TLGS examinations were required to sign an informed consent form.
Statistical analysis
Subjects aged 20–69 years were initially selected and categorized based on gender and five age groups. Then the prevalence of JNC-VI-based stages of SBP and DBP by gender and age groups were calculated by means of the SPSS 9.05 statistical software package (SPSS Inc., Chicago, IL, USA). Subjects who were using any antihypertensive prescription medication were excluded.
Results
Data for 8982 subjects (3823 men and 5159 women) over 19 years of age were included. The mean age of individuals was 40±13 years (41±14 and 39±13 years for men and women, respectively). Prevalence of blood pressure stages by sex on the basis of JNC-VI criteria according to both SBP and DBP, SBP alone, and DBP alone are shown in Table 1.
Based on both SBP and DBP (the JNC-VI), 71.8% of the cases had normal BP, 13.3% high normal BP, 11.1% hypertension stage 1, and 3.8% hypertension stage ≥2. For DBP alone, the corresponding values were 78.6, 10.2, 8.5, and 2.7%, respectively, compared with those of SBP alone (81.5, 9.6, 6.8, and 2.1%), and had less differences with values for both SBP and DBP (the JNC-VI). In 8.9% of the cases (10.0% of men and 8.1% of women), SBP was at a higher stage than DBP and it was 13.6% (14.3% of men and 13.2% of women) for DBP. In 77.4% of the cases (75.7% of men and 78.7% of women), SBP and DBP were in the same stage. This means that in 86.3% of the cases (85.7% of men and 86.8% of women), SBP was responsible for determining blood pressure stage and DBP alone had this responsibility in 90.0% of the cases (Table 1). The role of DBP in determining BP stage (ie DBP>SBP percent plus DBP=SBP percent in Table 2) was more prominent than SBP in all age groups, except for the 50–59 and 60–69 years age groups (Figure 1). This means that in 91.0% of the cases (90.0% of men and 91.9% of women), DBP was responsible for determining blood pressure stage and SBP alone had this responsibility in 86.3% of the cases (Table 2).
Effect of age
Table 2 displays frequencies of blood pressure stages on the basis of SBP and DBP in different age goups. In age groups 20–29 and 60–69 years, SBP was responsible for determining blood pressure stage in 91.4 and 90.8% of the cases respectively, but in the age group of 40–49 years blood pressure stage was determined on the basis of SBP in only 80.4% of the cases. The same pattern was seen in both gender, as shown in Figure 1. The role of SBP in determining blood pressure stage, however, was more prominent in lower and higher age groups. The role of SBP in determining blood pressure stage was the least in the middle-age group (40–49 years) in both genders (80.0 and 80.6% for men and women, respectively).
SBP tends to rise with increasing age, whereas DBP tends to have no notable change in the age group 50–59 years, when it begins to fall.
Discussion
There is a current inclination to consider SBP as a much more important risk factor of coronary artery disease.2,3,4,5,6,7,8,12,13,14 Lloyd-Jones et al2 stated that 64.6% of the subjects had congruent of stages of SBP and DBP; in 31.6%, SBP was at a higher stage than DBP and in 3.8%, DBP was at a higher stage than SBP. This means that SBP alone correctly classified the JNC-VI-based stage of blood pressure in nearly 96% of the cases.2 They stated that among subjects >60 years old, SBP alone correctly classified 99% of the subjects, and suggested that SBP appears to play a greater role in determining blood pressure stage and eligibility for that treatment of hypertension according to the JNC-VI criteria.2 Our study demonstrated a weaker role for SBP and a stronger role for DBP in this regard. When the BP was classified based on SBP alone, fewer cases were categorized into higher stages of BP than it is done based on DBP alone. The blood pressure of 91.0% of the subjects was classified according to DBP alone. SBP alone, however, correctly classified the blood pressure of 86.3% of the subjects. Therefore, in our sample DBP was a more superior determinant of blood pressure stage than SBP, compared with Western studies. A possible explanation for this finding may be the age of our study subjects. Our subjects were younger than those studied by Lloyd-Jones et al2 (40±13 vs 58±13 years). To explore the effect of age, our cases were stratified into five age groups and then the analysis was repeated. In this regard, the role of SBP in determining blood pressure stage was the greatest in age groups 20–29 and 60–69 years and the least in the age group 40–49 years. In the age group 60–69 however, this role was not as prominent as it was in Lloyd-Jones et al's study. The more eminent role of SBP in determining blood pressure stage is mostly because of the higher concordance of SBP and DBP in younger age groups (88.1%) and the higher prevalence of blood pressure class upstaged by SBP in older age groups (34.9%). Considering DBP, in 96.7% of the 20–29-years-old cases, it determined BP stage correctly. DBP determined BP stage correctly in 97.9, 94.4, 83.1, and 65.1% of 30–39, 40–49, 50–59, and 60–69-years-old cases, respectively. It is clear that only in those over 60 years old, SBP had an advantage over DBP in determining blood pressure stage, even though this advantage was not as strong as the study by Llyod-Jones et al.2 It is also obvious that in those who are 50–59 years old, neither SBP nor DBP can be used alone for BP staging, because in this case in almost 17% of people the staging will be wrong. In younger age groups, DBP is a good predictor of BP staging. One has to practice caution when analysing the BP measurement on those who are 40–49 years old in whom SBP alone can be used for correct staging of BP in only 80.4% of the cases, while DBP can be used in 94.4% of the cases.
Another possible explanation for a more prominent role of DBP over SBP in our subjects is the higher mean DBP level in Tehranians compared with the Western population,15 especially in the younger age groups.
With increasing age, the concordance of SBP and DBP decreases and blood pressure upstaging based on SBP becomes more likely. Blood pressure upstaging based on DBP is still high until 50 years old, but it tends to decrease when SBP becomes more prominent in determining blood pressure stage in older age groups. These findings may be because of a tendency of a rise in SBP with increasing age, whereas DBP tends to have no significant change after 50 years old, and actually after 60 years old it begins to fall slightly (Table 3) as noted in other studies.15,16
In conclusion, DBP seems to be a stronger predictor of BP staging than SBP in young and middle-aged people. A higher prevalence of high SBP in older age groups renders SBP more prodigious in staging blood pressure in older people. Therefore, the role of DBP in determining blood pressure stage in adults, especially in young and middle-aged subjects, should be considered more important than SBP.
References
The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446.
Lloyd-Jones DM et al. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood pressure. Hypertension 1999; 34: 381–385.
Pogue VA, Ellis C, Mechel J, Francis CK . New staging system of the Fifth Joint National Committee report on the detection, evaluation, and treatment of high blood pressure (JNC-V) alters assessment of the severity and treatment of hypertension. Hypertension 1996; 28: 713–718.
Black HR . The paradigm has shifted, to systolic blood pressure. Hypertension 1999; 34: 386–387.
Izzo JL, Levy D, Black HR . Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021–1024.
Kannel WB, Gordon T, Schwarts MJ . Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971; 27: 335–345.
Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316 099 white men. Arch Intern Med 1992; 152: 56–64.
Dustan HP . 50th Anniversary historical article: hypertension. J Am Coll Cardiol 1999; 33: 595–597.
Azizi F, Rahmani M, Emami H, Madjid M . Tehran Lipid and Glucose Study: rationale and design. CVD Prevention 2000; 3: 242–247.
Christiansen DH, Hosking JD, Dannenberg AL, Williams OD . Computer-assisted data collection in multicenter epidemiologic research: The Atherosclerosis Risk in Communities (ARIC) study. Control Clin Trials 1990; 11: 101–115.
Atherosclerosis Risk in Communities Manuals of Operation. No 12, Quality Assurance and Quality Control. ARIC Coordinating Center: Chapel Hill, 1997.
Wilson PW, Kannel WB . Hypertension, other risk factors and the risk of cardiovascular disease. In: Laragh JH, Brener BM (eds) . Hypertension: Pathophysiology, Diagnosis, and Management. Raven press: New York, NY; 1995, pp. 99–114.
Staessen JA et al. Randomised double-blind comparision of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757–764.
Neaton JD, Kuller L, Stamler J, Wentworth DN . Impact of systolic and diastolic blood pressure on cardiovascular Mortality. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press: New York, NY, 1995, pp. 127–144.
Burt VL et al. Prevalence of hypertesnion in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995; 25: 305–313.
Franklin SS et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308–315.
Acknowledgements
This research project was supported by a national Grant no. 121 NRCI Research Projects and with the support of the National Research Council of Islamic Republic of Iran. We express appreciation to the participants of district-13, Tehran, for their enthusiastic support of this study. We thank the appreciable work of the social relation unit and steering committee of TLGS for their guidance in preparing this paper. The participation of the staff of the Endocrine and Metabolism Research Center, Tehran Lipid and Glucose Study unit, Health Department of Shaheed Beheshti University of Medical Sciences is gratefully acknowledged. We also thank Dr Bahman Guyuron and Dr Martina Ferraro, who revised the English edition of the manuscript.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Azizi, F., Rashidi, A., Ghanbarian, A. et al. Is systolic blood pressure sufficient for classification of blood pressure and determination of hypertension based on JNC-VI in an Iranian adult population? Tehran lipid and glucose study (TLGS). J Hum Hypertens 17, 287–291 (2003). https://doi.org/10.1038/sj.jhh.1001539
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001539
Keywords
- classification
- TLGS (Tehran Lipid and Glucose Study)
- SBP
- DBP
